Dental Problems with Buprenorphine Dissolved in The Mouth to Treat Opioid Use Disorder (OUD) and Pain
The U.S. Food and Drug Administration (FDA) reports that patients that use medications containing buprenorphine that are dissolved in the mouth may experience dental problems.
Dental problems, including tooth decay, cavities, oral infections and loss of teeth, can be serious and have been reported even in patients with no history of dental issues.
Dental Problems with Buprenorphine Dissolved in The Mouth to Treat Opioid Use Disorder (OUD) and Pain
The U.S. Food and Drug Administration (FDA) reports that patients that use medications containing buprenorphine that are dissolved in the mouth may experience dental problems.
Dental problems, including tooth decay, cavities, oral infections and loss of teeth, can be serious and have been reported even in patients with no history of dental issues.
No Prior Authorization (PA) Needed for Insulin Used During Pregnancy
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
MaineCare will reimburse for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for pregnant patients without a PA when pregnancy is indicated on the prescription.
If you receive a denial of a prescription for Humulin or Novolin NPH insulin for prior authorization and pregnancy is indicated on the prescription, please contact the Change Healthcare Pharmacy Helpdesk at 1-888-420-9711 for a pregnancy override.
No Prior Authorization (PA) Needed for Insulin Used During Pregnancy
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
MaineCare will reimburse for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for pregnant patients without a PA when pregnancy is indicated on the prescription.
If you prescribe Humulin or Novolin NHP insulin to a patient who is pregnant, and the pharmacy refuses to fill the prescription or says that a PA is required, please call the Change Healthcare Provider Helpdesk at 1-888-420-9711.
No Prior Authorization (PA) Needed for Insulin Used During Pregnancy
Effective February 21, 2022, no PA is needed for insulin used during pregnancy.
Alert samples
Info alert
The PI Program has ended
The information below is archived information about the program.
Warning alert
The PI Program has ended
The information below is archived information about the program.
Electronic Visit Verification (EVV) Frequently Asked Questions (FAQs)
We have updated the EVV FAQs with a new question.
Electronic Visit Verification (EVV) Frequently Asked Questions (FAQs)
We have updated the EVV FAQs with a new question.